These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17367254)

  • 21. Study shows inappropriate drug scheduling.
    Cooper JW
    Nurs Homes Sr Citiz Care; 1988; 37(5):13-5. PubMed ID: 10290196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementing changes to the state operations manual.
    Martin CM; Saxton-McSpadden C
    Consult Pharm; 2007 Feb; 22(2):105-8, 110-2, 115-7. PubMed ID: 17367245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to clinical practice guidelines for 7 chronic conditions in long-term-care patients who received pharmacist disease management services versus traditional drug regimen review.
    Horning KK; Hoehns JD; Doucette WR
    J Manag Care Pharm; 2007; 13(1):28-36. PubMed ID: 17269834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles and responsibilities of attending physicians in skilled nursing facilities.
    Dimant J
    J Am Med Dir Assoc; 2003; 4(4):231-43. PubMed ID: 12837146
    [No Abstract]   [Full Text] [Related]  

  • 25. View from the other side: an interview with a pharmacist-surveyor. Interview with Jean Farley, RPh.
    Martin CM
    Consult Pharm; 2008 Jul; 23(7):520-4, 529. PubMed ID: 18764670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving antipsychotic prescribing practices in nursing facilities: The role of surveyor methods and surveying agencies in upholding the Nursing Home Reform Act.
    Urick BY; Kaskie BP; Carnahan RM
    Res Social Adm Pharm; 2016; 12(1):91-103. PubMed ID: 25990258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved medication use in long-term care: building on the consultant pharmacist's drug regimen review.
    Harjivan C; Lyles A
    Am J Manag Care; 2002 Apr; 8(4):318-26. PubMed ID: 11950127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceived clinical significance of consultant pharmacist recommendations in the skilled nursing facility.
    Miller DA; Lucarotti RL; Vlasses PH; Krigstein DJ; McKercher PL
    Drug Intell Clin Pharm; 1980 Mar; 14(3):182-6. PubMed ID: 10246655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assisted Living Facilities: The Next Frontier for Consultant Pharmacists.
    Coulson E; Blaszczyk AT
    Consult Pharm; 2016 Feb; 31(2):107-11. PubMed ID: 26842688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescribing under OBRA. Myth and reality.
    Weiss KJ
    N J Med; 1991 Feb; 88(2):117-8. PubMed ID: 2002893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consultant pharmacist drug therapy recommendations from monthly drug regimen reviews in a geriatric nursing facility: a two-year study and cost analysis.
    Cooper JW
    J Nutr Health Aging; 1997; 1(3):181-4. PubMed ID: 10995088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The health care cost of drug-related morbidity and mortality in nursing facilities.
    Bootman JL; Harrison DL; Cox E
    Arch Intern Med; 1997 Oct; 157(18):2089-96. PubMed ID: 9382665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nursing home medical director role in transition.
    Elon R
    J Am Geriatr Soc; 1993 Feb; 41(2):131-5. PubMed ID: 8426034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines for medication therapy management services in long-term care facilities.
    Medication Therapy Management Task Force, American Society of Consultant Pharmacists
    Consult Pharm; 2007 Apr; 22(4):355-61. PubMed ID: 17658966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The preliminary impact of Maryland's medical director and attending physician regulations.
    Boyce BF; Bob H; Levenson SA
    J Am Med Dir Assoc; 2003; 4(3):157-63. PubMed ID: 12854990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profile of physicians in the nursing home: time perception and barriers to optimal medical practice.
    Caprio TV; Karuza J; Katz PR
    J Am Med Dir Assoc; 2009 Feb; 10(2):93-7. PubMed ID: 19187876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to the components of the Fleetwood model: self-reported process measures in the Fleetwood Phase III study.
    Lapane KL; Hughes CM
    Consult Pharm; 2006 Dec; 21(12):981-7. PubMed ID: 17243849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication reconciliation for reducing drug-discrepancy adverse events.
    Boockvar KS; Carlson LaCorte H; Giambanco V; Fridman B; Siu A
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):236-43. PubMed ID: 17062324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The medication regimen review: building rapport with the consultant pharmacist.
    Otto KJ; Bergman-Evans B
    J Gerontol Nurs; 2013 Oct; 39(10):3-4. PubMed ID: 24087975
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of the consultant obstetrician in the delivery suite.
    Hackett M; Gee H
    J Manag Med; 1998; 12(2-3):101-8, 79. PubMed ID: 10185762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.